<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39412365</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>Addressing SARS-CoV-2 viroporins with antiarrhythmic drugs.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">euae254</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/euae254</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bloothooft</LastName><ForeName>Meye</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0614-8885</Identifier><AffiliationInfo><Affiliation>Department of Medical Physiology, Division of Heart &amp; Lungs, University Medical Center Utrecht, Yalelaan 50, 3584 CM Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voigt</LastName><ForeName>Niels</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-8230-2341</Identifier><AffiliationInfo><Affiliation>Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Göttingen, Göttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cluster of Excellence 'Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells' (MBExC), University of Göttingen, Göttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Boer</LastName><ForeName>Teun P</ForeName><Initials>TP</Initials><Identifier Source="ORCID">0000-0002-0561-6491</Identifier><AffiliationInfo><Affiliation>Department of Medical Physiology, Division of Heart &amp; Lungs, University Medical Center Utrecht, Yalelaan 50, 3584 CM Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>114022502</GrantID><Acronym>ZONMW_</Acronym><Agency>ZonMw</Agency><Country>Netherlands</Country></Grant><Grant><GrantID>81X2300189</GrantID><Agency>DZHK</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>doi: 10.1093/europace/euae252</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="Y">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Conflict of interest: none declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>9</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39412365</ArticleId><ArticleId IdType="pmc">PMC11481343</ArticleId><ArticleId IdType="doi">10.1093/europace/euae254</ArticleId><ArticleId IdType="pii">7823655</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dhakal BP, Sweitzer NK, Indik JH, Acharya D, William P. SARS-CoV-2 infection and cardiovascular disease: COVID-19 heart. Heart Lung Circ 2020;29:973–87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7274628</ArticleId><ArticleId IdType="pubmed">32601020</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewland TA, Marcus GM. SARS-CoV-2 infection and cardiac arrhythmias. Nat Cardiovasc Res 2022;1:1109–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9684811</ArticleId><ArticleId IdType="pubmed">36465413</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedmann F, Boondej E, Stanifer M, Paasche A, Kraft M, Prüser Met al. . SARS-CoV-2 ORF 3a-mediated currents are inhibited by antiarrhythmic drugs. Europace 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">39412366</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlton FW, Pearson HM, Hover S, Lippiat JD, Fontana J, Barr JNet al. . Ion channels as therapeutic targets for viral infections: further discoveries and future perspectives. Viruses 2020;12:844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7472218</ArticleId><ArticleId IdType="pubmed">32756358</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieva JL, Madan V, Carrasco L. Viroporins: structure and biological functions. Nat Rev Microbiol 2012;10:563–74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097105</ArticleId><ArticleId IdType="pubmed">22751485</ArticleId></ArticleIdList></Reference><Reference><Citation>Hover S, Foster B, Barr JN, Mankouri J. Viral dependence on cellular ion channels—an emerging anti-viral target? J Gen Virol 2017;98:345–51.</Citation><ArticleIdList><ArticleId IdType="pubmed">28113044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Ejikemeuwa A, Gerzanich V, Nasr M, Tang Q, Simard JMet al. . Understanding the role of SARS-CoV-2 ORF3a in viral pathogenesis and COVID-19. Front Microbiol 2022;13:854567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8959714</ArticleId><ArticleId IdType="pubmed">35356515</ArticleId></ArticleIdList></Reference><Reference><Citation>Fam MS, Sedky CA, Turky NO, Breitinger H-G, Breitinger U. Channel activity of SARS-CoV-2 viroporin ORF3a inhibited by adamantanes and phenolic plant metabolites. Sci Rep 2023;13:5328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10067842</ArticleId><ArticleId IdType="pubmed">37005439</ArticleId></ArticleIdList></Reference><Reference><Citation>Breitinger U, Sedky CA, Sticht H, Breitinger H-G. Patch-clamp studies and cell viability assays suggest a distinct site for viroporin inhibitors on the E protein of SARS-CoV-2. Virol J 2023;20:142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10329798</ArticleId><ArticleId IdType="pubmed">37422646</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison NL, Abbott GW, Gentzsch M, Aleksandrov A, Moroni A, Thiel Get al. . How many SARS-CoV-2 “viroporins” are really ion channels? Commun Biol 2022;5:859.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9411608</ArticleId><ArticleId IdType="pubmed">36008538</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AN, Houlihan PR, Matamala E, Cabezas-Bratesco D, Lee GY, Cristofori-Armstrong Bet al. . The SARS-CoV-2 accessory protein Orf3a is not an ion channel, but does interact with trafficking proteins. eLife 2023;12:e84477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9910834</ArticleId><ArticleId IdType="pubmed">36695574</ArticleId></ArticleIdList></Reference><Reference><Citation>Walia K, Sharma A, Paul S, Chouhan P, Kumar G, Ringe Ret al. . SARS-CoV-2 virulence factor ORF3a blocks lysosome function by modulating TBC1D5-dependent Rab7 GTPase cycle. Nat Commun 2024;15:2053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10918171</ArticleId><ArticleId IdType="pubmed">38448435</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum JC, Carlson AE. The SARS coronavirus accessory protein ORF3a rescues potassium conductance in yeast. MicroPubl Biol 2024;2024. doi:10.17912/micropub.biology.001129</Citation><ArticleIdList><ArticleId IdType="doi">10.17912/micropub.biology.001129</ArticleId><ArticleId IdType="pmc">PMC10958204</ArticleId><ArticleId IdType="pubmed">38525126</ArticleId></ArticleIdList></Reference><Reference><Citation>Seibertz F, Voigt N. High-throughput methods for cardiac cellular electrophysiology studies: the road to personalized medicine. Am J Physiol Heart Circ Physiol 2024;326:H938–H49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11279751</ArticleId><ArticleId IdType="pubmed">38276947</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>